Riskpilot← Back to searchSign inGet full accessJÆREN LEGESENTER AS
ASActiveOrg 914179114Kjøpmannsbrotet 5, 4351 KleppeGeneral medical practice activities · NACE 8621Est. 20145 employees
Revenue 2025
NOK 6,1M
-2% vs 2024
EBITDA margin
1.4%
-39% vs 2024
Equity ratio
24.3%
Financial strength
Net profit 2025
NOK 855
+57% vs 2024
| Revenue | NOK 6,1M | -2% |
| EBITDA | NOK 86K | -39% |
| Net profit | NOK 855 | +57% |
| Total assets | NOK 2,5M | +13% |
| Equity | NOK 602K | +0% |
| Employees | 5 | — |
Legal name
JÆREN LEGESENTER AS
Org number
914179114
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. september 2014
Share capital
NOK 300 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter, stille utstyr og personell til rådighet for leger tilknyttet senteret. Handel, hva dermed står i forbindelse, samt deltakelse i andre selskaper med lignende formål.
Address
Kjøpmannsbrotet 5, 4351 Kleppe
Phone
+4751204400
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 429 | 5 849 | 5 904 | 6 196 | 6 072 |
| Staff expenses | −2 573 | −2 678 | −2 821 | −3 057 | −3 060 |
| EBITDA | 202 | 172 | 140 | 142 | 86 |
| Depreciation & amort. | −155 | −156 | −141 | −140 | −79 |
| EBIT | 46 | 16 | −1 | 2 | 7 |
| Net financials | −4 | −2 | 1 | −1 | 1 |
| Profit before tax | 42 | 14 | 0 | 1 | 8 |
| Tax | 1 | 3 | 0 | 1 | 7 |
| Net profit | 41 | 11 | 0 | 1 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 111 | 2 108 | 2 159 | 2 187 | 2 473 |
| Equity | 733 | 600 | 600 | 601 | 602 |
| Long-term debt | 1 | 4 | 4 | 0 | 0 |
| Short-term debt | 1 377 | 1 504 | 1 554 | 1 586 | 1 871 |
| Total debt | 1 378 | 1 508 | 1 558 | 1 586 | 1 871 |
EBITDA margin
1.4%
This company
15.8%
Market median
-91% vs market
20212025
Equity ratio
24.3%
This company
38.2%
Market median
-36% vs market
20212025
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20212025
Debt / equity
3.11×
This company
0.62×
Market median
-402% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 | |
| Individual | 16.67% | 16.67% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JÆREN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|